Palbociclib Hydrochloride (20:37) and its Impurities

Palbociclib Hydrochloride (20:37), sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride (20:37) API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for Palbociclib Hydrochloride (20:37) Impurities
PA 16 4130000

Palbociclib Hydrochloride (20:37)

Palbociclib Hydrochloride (20:37)

  • Catalogue No.:PA 16 4130000

  • CAS :

    571189-11-2

  • Molecular Formula : 20(C24H29N7O2) . 37(HCl)

  • Molecular Weight : 20(447.54) + 37(36.46)

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
CPHI INDIA- 28, 30 November